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Aim: To create sustained improvements in medical students’ critical thinking skills through short teaching
interventions in pharmacology.
Method: The ability to make professional decisions was assessed by providing year-4 medical students at a UK
medical school with a novel medical scenario (antenatal pertussis vaccination). Forty-seven students in the 2012
cohort acted as a pretest group, answering a questionnaire on this novel scenario. To improve professional
decision-making skills, 48 students from the 2013 cohort were introduced to three commonly used medications,
through tutor-led 40-min teaching interventions, among six small groups using a structured presentation of
evidence-based medicine and ethical considerations. Student members then volunteered to peer-teach on a
further three medications. After a gap of 8 weeks, this cohort (post-test group) was assessed for professional
decision-making skills using the pretest questionnaire, and differences in the 2-year groups analysed.
Results: Students enjoyed presenting on medications to their peers but had difficulty interpreting studies and
discussing ethical dimensions; this was improved by contextualising information via patient scenarios. After
8 weeks, most students did not show enhanced clinical curiosity, a desire to understand evidence, or ethical
questioning when presented with a novel medical scenario compared to the previous year group who had
not had the intervention. Students expressed a high degree of trust in guidelines and expert tutors and felt
that responsibility for their own actions lay with these bodies.
Conclusion: Short teaching interventions in pharmacology did not lead to sustained improvements in their
critical thinking skills in enhancing professional practice. It appears that students require earlier and more
frequent exposure to these skills in their medical training.
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P
rofessionalism defines the values of a doctor and
is set out by the General Medical Council (GMC)
for today’s UK doctors (1); among these is ‘make
the care of your patient your first concern’. Duties of a
Doctor in Good Medical Practice (1) also states ‘you
are personally accountable for your professional practice
and must always be prepared to justify your decisions
and actions’. This is further discussed, under Good clini-
cal care 16e, in the ‘GMC document Medical students:
professional values and fitness to practice’, which states
‘treatment should be based on clinical need and the
effectiveness of treatment options, and that decisions
should be arrived at through assessment and discussion
with the patient’ (2).
Justifying decisions requires an understanding of con-
temporary knowledge, and whilst advances in medical
understanding, therapies, and the world wide web have
made large numbers of research articles available from
around the world, it also makes individually knowing
all available research, or even knowing best resources,
less likely. For example, hypertension has been treated
since the mid-1980s (3). A search on the university online
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library for terms ‘primary prevention of hypertension’
gave 13,426 results in 2014 and on ‘hypertension’ reveals
1,336,878 results. Most medical students still prefer to
read textbooks in the UK, and there is understandable
poor discrimination about which online resources they use
(4). The development of internet-supported authorities,
reviews, guidelines, and risk scores help to provide
solutions to clinical scenarios, but at the expense of
individual critical thinking skills, that is, students may
develop a knee jerk learnt solution to a prescribing issue
rather than learning to think through the problem.
Maudsley and Strivens (5) noted that ‘British under-
graduate curricula have long struggled to prevent factual
overload from suppressing critical thinking’. Facione
et al. (6) identified in professional decision-making ‘pro-
blem resolution’, which may be taught through guidelines,
and ‘problem framing’. The student who has framed
the wrong professional question may reach the wrong
resolution. Rather than train students to every eventuality,
university education should encourage students to ask
professional questions of the specific context, so that stu-
dents frame questions which become transferable across
different scenarios. Facione identified critical thinking and
inquisitiveness as two of seven personality traits associated
with good skills in problem framing and problem solving,
and these should be encouraged. Students need to think
objectively, analyse evidence-based medicine (EBM),
justify the beliefs they are developing, and share those
with their peers. I share Winters and Echeverri’s (7) view of
the teaching of EBM which is described as: 1) ask the
clinical question; 2) search for best evidence; 3) critically
appraise the evidence; 4) integrate the evidence into
practice; and 5) evaluate the outcomes.
Winters and Echeverri (7) identified barriers to teaching
EBM as: lack of knowledge, belief, and skills regard-
ing EBM; lack of critical appraisal skills; and taking too
much on. Prescribing scenarios are particularly complex as
there are medical system issues, for example, renal func-
tion, interactions, safety, convenience, monitoring, length
of therapy, changes in patient conditions, balances be-
tween short- and long-term outcomes, costs, and patient
views. After analysing information, students and doctors
need to create outcomes. Outcomes are described by Porter
(8) as inherently condition-specific, multidimensional, and
factors requiring weighing against each other. This moves
Winters’ EBM skills into ethical areas. For this study,
I advocated the Beauchamp and Childress’ ethical princi-
ples (9) of beneficence, non-maleficence, autonomy, and
justice because the students had been taught these in
previous years.
Prescribing was chosen as the professional thinking
exemplar because of increasing patient co-morbidities
and polypharmacy, risking harms, side-effects, and inter-
actions. Hagstrom et al. (10) surveyed patients and found
that individuals declaring a chronic disease ‘increased
from 23% in 1980 to nearly 40% in 2000’. The National
Patient Safety Agency (11) reports that 6.5% of hos-
pital admissions were related to medication issues, of
which 9% were definitely preventable. Drugs most
commonly associated with harms were aspirin, diuretics,
warfarin, and non-steroidal anti-inflammatory drugs,
usually causing gastrointestinal haemorrhage. The Medi-
cines and Healthcare Products Regulatory Authority
received 297 reports of fatality to warfarin (an antic-
oagulant) between 1963 and 2008 (12). About 700 deaths
per year in the UK are considered to be directly attri-
butable to medications and also preventable. The GMC
publication ‘Good practice in prescribing and managing
medicines and devices’ (13) aims to improve prescrib-
ing skills. In addition, a Prescribing Safety Assessment
examination has been introduced to medical schools
throughout the UK, so medical students should be gaining
understanding of evidence for drug use, indications, and
starting to critically assess their prescribing decisions.
It is on this background that I chose to discuss medi-
cations as a vehicle for improving professional decision-
making. In creating future professionals, medical students
are encouraged to act as active self-directed learners to
build on prior learning, explore known concepts, and
analyse new knowledge and experiences (14). The role of
the tutor is to discover what the student already knows
and then act as a mentor to provide ‘scaffolding’, which
allows the students to work out best ways to learn
autonomously. Using these principles in this study, the
students were offered constructivist learning opportunities
to progress from novice to life-long learners and improvers
as clinicians.
Methods
Pretest and post-test study: student critical thinking
using antenatal pertussis vaccination scenario
To explore approaches to problem solving with year-4
students in the 20122013 academic year, I gave them
a short questionnaire exploring student attitudes and
knowledge of antenatal whooping cough (pertussis) vacci-
nation (Appendix 1). The questionnaire was wide ranging
so that students would not try to predict tutor-wanted
responses. The questions relating to the study are numbers
1, 2, 5, 6, and 12. Answering it was voluntary, 47 students
returned the form and 1 student did not.
In April 2012 in the UK, the Health Protection Agency
declared a level 3 incident response to rising levels of
pertussis in neonates and recommended vaccination of
women between 28 and 38 weeks of pregnancy with a
vaccine containing pertussis, diphtheria, and tetanus from
October 2012 (15). Antenatal vaccination has little pre-
cedent; in 2008, flu pandemic antenatal influenza vaccine
was used, and postvaccination surveillance suggested a
small risk of narcolepsy related to Pandremix vaccination
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in offspring. Little is known about actual risk, in vivo
vaccination transfer from mother to foetus, and potential
problems with adjuvants (16). Pertussis vaccine, given
as Repevax, contains acellular pertussis, diphtheria, teta-
nus and polio, formaldehyde, glutaraldehyde, neomycin,
streptomycin, polymyxin B, or bovine serum albumin.
Antenatal vaccination with pertussis was therefore used
as a scenario to which students would not have an ‘off
the peg’ response, guideline, app., or e-resource readily
available. This pretest study was in conjunction with
another clinical tutor to gain necessary numbers. At the
next meeting, students were asked; ‘How do you feel about
performing a new skill?’ and ‘What would you want before
doing a new skill?’ in order to encourage a discussion
of attitudes and critical thinking  themes were then
brought together by the two tutors.
This same questionnaire and discussion was undertaken
as a post-test study in the 20132014 medical student
group but only by one tutor, 8 weeks after the prescrib-
ing interventions and the 2-year group results com-
pared. The expected outcome was that the second group
would display improved critical thinking and professional
questioning.
Prescribing interventions
The intervention group was six groups of 610 fourth
year medical students whom I tutored for 1 day every
2 weeks throughout their academic year 20132014. At
three meetings, 40-min teaching topics were introduced
on the commonly used medications: aspirin, tiotropium,
and simvastatin (Appendices 24). The teaching was
subdivided into four parts:
1. Tutor and student discussion of facts about the
chosen drug. A table of important facts was estab-
lished to improve and uniform baseline knowledge.
2. Tutor questioning about drug effectiveness in a
specific common scenario to verbalise drug efficacy
beliefs among students. Presentation of a major
trial in abbreviated form, outlining method of study,
with headline outcome numbers of benefits and
harms. Students were asked to respond to the EBM
information.
3. Students were asked ‘what other considerations
are there in prescribing, beyond EBM, and the facts
about the drug?’ This was frequently rephrased,
due to lack of response, to ‘can you tell me any
ethical principles that could be used in deciding
whether to prescribe?’ The students recalled the
BeauchampChildress four ethical principles and
were encouraged to relate these to the medication.
4. A variety of scenarios were discussed in which
different prescribing judgements might be made
with the understanding that no one answer would
always be right but that there was an effort at best
professional judgement.
The three scenarios used were: aspirin after a heart attack,
the use of tiotropium handihaler in chronic obstruc-
tive airways disease (COPD), and use of simvastatin to
reduce cholesterol in patients with coronary heart disease
(CHD). Over the 6 weeks, students became accustomed
to the structure of the teaching, to critically analysing
EBM, and discussing ethical aspects of prescribing.
To offer a variety of tutor methods to allow students
to find EBM resources, practice critical analyses, and
to model their behaviour on my interventions, I asked
a student in each group to volunteer to tutor on another
medication of their choice, or suggested by myself.
I helped students find respected EBM resources online
if asked. They were asked to follow the same tutoring
format. Each of the six groups, therefore, had a further
three teaching interventions over 6 weeks but by peers.
A total of six medications were discussed over the study
for each group.
During student presentations, I made notes using a
table to note if EBM and ethical issues had been discussed.
I was keen that students remained autonomous thinkers
and that I did not create another ‘guideline’ on how to
think so I encouraged questions and problem framing
rather than answers.
After the six interventions there was an 8-week gap in
which we did not discuss EBM and critical thinking
unless initiated by students. I then administered the post-
test part of the study as above.
The study had ethical approval from the university
(study 201208117). Students were not consented into the
study for two reasons: first, it was impossible if students
did not consent to exclude them from participation as
the study took place in usual teaching sessions. Second,
if students were consented into a study to look at ethical
behaviour they might perform to the study outcomes
rather than offer true opinions of patient problems and
management. At all times, participation in discussion,
teaching peers, and filling in the final questionnaire was
voluntary among the students.
Results
Prescribing interventions
When students asked about drug information, they
wanted information as found in the British National
Formulary (BNF). When asked about further information
they asked about serious interactions, illnesses that they
should aware of when prescribing, overdose, effects in
pregnancy, and cost. Students did not ask about EBM
of action, EBM of benefits, or harms initially; although
they learnt this over the three cycles and were interested.
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Students were asked how effective they thought the
drug was in the scenario and were encouraged to guess.
The figure for benefit of aspirin in preventing further
heart attack or angina in secondary prevention patients
was estimated as highly effective, mode 70% effective 
when encouraged to round down the lowest guess was
17%. Students were very surprised at the lack of magnitude
of efficacy of aspirin and other medications. They vastly
overestimated effect and underestimated harm. Reactions
to this were, ‘so medications aren’t as good as we thought
they would be’ and ‘I wouldn’t take it’.
Students enjoyed talking about trials but were not
used to handling information and made simple errors in
summating patient numbers, dropouts, and percentages
and were unable to critique studies accurately. After the
first session, I gave them printouts so that they had the
figures before them as well as on the white board and
could take them home.
Students did not consider ethical principles, for exam-
ple, benefits, harms to patients and society, and autonomy
without prompting. They struggled to use these in an
abstract manner and improved when patient contexts were
used. When initially asked to consider ethical principles
in prescribing, two comments were, ‘Oh, is this an ethi-
cal question then?’ and ‘Is it the society, groups, and
individuals stuff?’
Students chose to present on amoxicillin, ramipril,
metformin, citalopram, ibuprofen, and amlodipine. Stu-
dents generally followed the tutor format but it was
unusual to have the evidence well-presented, and errors
were common. Students suggested resources like National
Institute for Clinical Excellence (NICE) clinical guidance,
Health and Social Care Information Centre, found their
own references, and went to a lot of trouble to review the
information. Interpretation was variable, and some student-
tutors could not distinguish absolute risk reduction from
relative risk reduction, so overestimated drug effects.
Students used PowerPoint and handouts. Some students
rejected suggested trials in favour of other meta-analyses,
one student introduced Forest Plots. Two students intro-
duced groups to Patient Decision Aids. A few stu-
dents used numbers needed to harm (NNH) and numbers
needed to treat (NNT) as markers of effect. One student
discussed with the group about clinical trials and lack of
grey (unpublished evidence) and called on the group to
sign the petition at www.alltrials.com. Students found
Patient Decision Aids, NNH, and NNT most effective.
Student-tutors who presented varying patient scenarios
created more discussion with peers about harms and
benefits than those who did not contextualise prescribing
scenarios.
Students had difficulty formulating ethical questions.
Student-tutors and I resorted to asking the group personal
questions, for example, ‘What if I were to give you this
drug tomorrow?’ and ‘What if the patient says, do I really
need to take this drug, doctor?’ Only one student discus-
sed that a 3% reduction in death from heart attack was
highly significant across the UK population, others were
likely to say, ‘Well, I wouldn’t take it’. One student sug-
gested placebo drug use. Most students wanted to
prescribe amoxicillin despite contrary evidence of benefit.
Responses to not prescribing amoxicillin were ‘get a good
lawyer’, ‘explain the EBM’, ‘get a sputum sample or
a CXR’, ‘stop doing medicine’, ‘prepare for aggression’,
‘go to Spain and stock up’, and ‘self-treat with home
remedies’. There was some discussion about public health
campaigns. In discussing autonomy and amoxicillin use,
one student told the group, ‘I would tell them they had
to take it or they would die’. When asked if that would be
true the reply was, ‘Not really’. A response in relation to
ethics was, ‘It’s really confusing’. There was therefore
concern that unless guidance was followed patients might
litigate or complain. Some students’ prescribing prefer-
ences were directed by their own illness experience despite
the evidence. A discussion about not prescribing creating
patient aggression led to a student-observed anecdote
of a patient becoming aggressive in a GP consultation.
Students lacked non-prescribing consultation skills and
management plans and wanted to share concerns about
complaints.
During the gap of 8 weeks, I did not discuss prescrib-
ing issues, EBM, or ethics unless they came up in case
presentations. On one occasion, a student gave a patient-
centred presentation but did not connect the patient’s
warfarin (an anticoagulant) prescription to the patient’s
complaint of haemoptysis: this student had not criti-
cally assessed the patient’s medications. Students did not
continue to discuss EBM or ethics in presenting case
histories. Compared to previous years, however, I found
the case presentations contained more patient information
about function and views.
Pretest and poststudy questionnaires
In the pretest study, 47 students handed back the ques-
tionnaire, one did not.
In the post-intervention group after 8 weeks, 42 stu-
dents (six students were absent due to illnesses) were
asked to complete the questionnaire and they all
handed them back. The full results of the 20122013
and 20132014 year groups’ responses are in Appendix 1.
The results relevant to the prescribing intervention are
in Table 1.
Responses to question 1 confirmed that this was a novel
scenario for these medical students, which was the inten-
tion of the study. Ninety-five percent of students post
interventions were dissatisfied with their knowledge of
antenatal pertussis vaccination yet 88% (question 2 parts
1, 2, and 3) would give the vaccination; this figure is 87%
in the pretest group. The only clear disparity between
the pretest and post-intervention students’ responses
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was that post-intervention students were more likely to
have concerns about maternal harm. There was some
small change in post-intervention students being less
certain about concerns of foetal harm in vaccination.
In the free text boxes, students from both groups
commented that they knew nothing about pertussis
vaccination in pregnancy and would like to know more.
The preliminary group made 17 comments and the study
group made 28 comments (question boxes 1, 2, 5, 6, and
12, Appendix 1), a number commenting that they required
more information in order to make decisions. Nevertheless
in both groups, despite misgivings, students overwhel-
mingly would give the vaccination if asked.
Two weeks later the post-intervention students were
given the results above and asked two questions ‘How do
you feel about performing a new skill?’ and ‘What would
you want before doing a new skill?’
All groups were clear that they would trust the
expert asking them to give the vaccine. Responsibility for
long-term side-effects due to vaccination would lie with
guideline authorities. A few students mentioned risks of
anaphylaxis but, when asked if they knew if adrenaline
for anaphylaxis would be present, said they would not
check but assumed so. They stated that anaphylaxis
was rare and that the nurse would be trained to manage
it. Rates of anaphylaxis are rare at about 1 in 1,000,000
vaccinations (17). Students were pleased to take on new
skills, though occasionally anxious, but did not feel a
need for EBM or ethical consideration. Comments made
were ‘we are asked to do new things all the time so just get
on with it’. This response was exactly the response of the
pretest student groups. The only difference was that some
of the post-test students stated that ‘I know it’s wrong
and we should think about the vaccination but in practice
we don’t’.
Therefore, short teaching interventions in pharmacol-
ogy did not lead to clear sustained improvements in
medical students’ critical thinking skills in enhancing
professional practice. Barriers to conversations about
professional decisions related to poor EBM interpre-
tation skills, reluctance to change practice, and not
recognising common prescribing scenarios as having
ethical dimensions.
Discussion
This study confirmed that professional thinking skills
need to be taught explicitly in the medical curriculum at an
early stage and be developed over the years. Donaldson
et al. (18) reported on students who had been asked to
bring ethical cases for discussion and found that many
focused on legal obligations rather than the morality of
what should be done. In addition, he found students
identified ethical issues as occurring at times of conflict in
medical management and that students can describe ethi-
cal issues but were not used to applying them in decision-
making. This is in agreement with this study. Students
require practice in logic and reasoning skills and placing
them in a value-laden practice, which is patient centred;
this could be encouraged by experts vocalising their decision-
making processes more explicitly. The apprentice  master
model of clinical placements in undergraduate medical
education  relies on students mimicking expert behaviour.
Students are rarely asked their views in scenarios (parti-
cularly when best practice is not obvious or not guideline
driven), have intellectual conversations about best prac-
tice, or allowed to propose alternative management plans.
Table 1. Results of survey into student attitudes to antenatal pertussis vaccination pretest and post-intervention groups
Question
number and
response Statements from questions
Non- intervention group (pretest);
% of students choosing these
options (total number of
students: 47)
Post-intervention group (post-test);
% of students choosing these
options (total number of
students: 42)
1. parts 3 and 4 Dissatisfied with their knowledge of vaccination
of pertussis in pregnancy
91 95
2. parts 1 and 2 Would vaccinate in pregnancy 19 24
2. part 3 Would not be confident to vaccinate but would
do so after checking with nurse or online as it is
a government recommendation
68 64
5. parts 1 and 2 Had concerns regarding maternal harm in
vaccination
4 31
5. part 3 Were unsure whether they had concerns or not,
about maternal harm
43 55
6. parts 1 and 2 Had concerns about harms to the baby 30 29
6. part 3 Were unsure whether they had concerns or not,
about harm to the baby
47 55
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A number of student-tutors emailed in advance or
asked in the presentation if they were ‘doing the right
thing’. Freeing students to appreciate that there was no
right and no wrong answer to problems led to an increase
in maturity of discussion with consideration of patient
values in case and topic teaching discussions until the end
of the year.
The study was limited by time, the intervention was
limited to 40 min and this particularly limited the feedback
that could be given to the student-tutor contributors,
and general end-of-session feedback to emphasise learn-
ing points or provoke further reflection. There was only
myself delivering the study and assessing the outcomes;
this study would have been much stronger with peer-tutor
review and a peer-tutor in class observation making a
note of emerging themes. There may have been effects
of my own values on topic teaching and interpretation
of comments, which might affect the validity of results
and identification of themes. It was difficult to listen to
students facilitating the group, respond when required,
and make observational notes about content. Using direct
quotations allowed some accurate recording of activity.
A form created to record student activity was not easy to
use or adequate in recording themes.
The study benefitted from using small groups who had
already met on five occasions with tutor-led and peer-peer
teaching of topics, so the study slotted into the day. As
there was already trust between tutor and small groups,
the reflections were honest. Starting the study towards the
end of the first term meant that stretching the student
learning to encompass professional thinking felt natural
over the year. Having all students blinded to the study
meant that discussions were frank and honest and is a
major strength of this study. In developing a number of
teaching interventions, the students were able to evaluate
medications, scenarios, online resources, and practice
skills improvement over a number of months.
The choice of antenatal pertussis vaccination could
be criticised as relating professional thinking to a skill
in which instructional method might be more usual but
I believe that all medical actions should belong to a
reflective practitioner who is able to consider whether
undertaking the procedure is in the best interests of the
patient. In setting up professional scenarios, practice
becomes quickly outdated and tutors require signposting
to resources to get started and need to create a repository
of respected resources, clinical cases using context, in-
formation, and ethical aspects, to create decisions and
quality assurance and reflection of these.
Conclusion
In conclusion, students were not able to transfer skills
developed in professional decision-making to a novel med-
ical scenario. They have no in-depth knowledge of likely
incidence or prevalence of harms and benefits of com-
monly used medications and so made highly inaccurate
assumptions. Medical students need to contextualise
facts, evidence, and ethical information and consider
patient individual factors before arriving at decisions.
It may be that students are able to consider ethical issues
but reserve judgement without more information and
find abstract decision-making unsatisfactory. The early
development of professional questioning would help stu-
dents to mature. I think that tutors should encourage
experimental thought and error to gain best ways of
decision-making and best decisions which then translate
into good decisions in clinical practice, for example,
good prescribing decisions. Professional questioning
would allow students to have an overview of medical
management. In this study, medical students were unable
to progress in answering therapeutic questions as they
hesitated at the EBM content, lacked skills in interpreta-
tion and were then reluctant to discuss an overview of
patient prescribing without this. This inability to develop
overarching professional views meant that most students
were willing to give vaccinations in novel circumstances
(pregnancy) despite a lack of knowledge and were not
willing to take responsibility for their decision.
Skills training and resource pointing to interpret EBM
to decide best evidence in the specific patient circum-
stances could be fixed within a framework of indivi-
dualised patient scenarios with ethical-based values in
order to foster open appraisal of benefits and harms
which might run counter to preconceptions. This requires
time to let students practice skills over a number of
scenarios during all of their training  in this way,
students can choose to develop attitudinal and epistemo-
logical change. Students should be encouraged to explore
their understanding that outcomes can be uncertain;
influenced by evidence, context, and patient choice; and
be multiple. This requires freeing up medical curriculums
into less content-heavy syllabuses and allowing experi-
mentation of ideas in class and on clinical placements.
This requires a change in tutor culture and timing;
in practice, it is easier to train a medical student to
identify a problem and select a known accepted response.
Is this what society would like from its doctors? Does it
provide the best care? If it does then it is possible that
medical school training could be provided as a distance
learning knowledge base and later clinical expert
apprentice model.
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Appendix 1.
Responses to Whooping cough vaccination in pregnancy questionnaire year 4 medical students
Pretest year 20122013 in bold and post-test study group 20132014 cohort in italics
Whooping cough vaccination in pregnancy. There were 47/48 replies 42/48 replies
Please assume your area GP StR1 and a pregnant woman attends your next surgery session when replying.
1. Do you feel knowledgeable about whooping cough vaccination in pregnancy? Please delete the responses not applicable
leaving the response you most agree with.
2. What is your personal position about vaccinating a pregnant woman against whooping cough?
Please delete the responses not applicable leaving the response you most agree with.
3. Should women post-partum be vaccinated against whooping cough?
Don’t know23. 11 Yes12. 14 No4 11
Comments: ‘I would have to look this up’
‘I have no knowledge re evidence for efficacy’
‘The benefit is for the baby so there is no benefit in giving post-partum vaccination to the mother’
‘Vaccination should be given if there is enough evidence that it is beneficial and cost effective, etc.’
4. a) Do you understand the mechanism of vaccination in pregnancy?
Don’t know4. 3 Yes11. 11 No24. 26
b) Does the vaccination cause maternal antibody production and transfer of these antibodies to the foetus or does it
cause the foetus to produce antibodies?
Maternal antibodies are transferred17. 23 Don’t know18. 14 Both1 Foetal produces antibodies3. 3
Comment: ‘I would have to look this up’
c) Would an understanding of the science of antibody transfer and production across the placenta be something you
would be interested in?
Yes35. 38 No5. 3 Maybe2
Comments: ‘I definitely need more teaching on this’
‘I am a bit interested but only in the clinical relevance’
‘This is an important topic and with anything in medicine patient lives are at risk therefore doctors should always consider
the consequences’.
Pretest Post-test
1. I am very knowledgeable about whooping cough vaccination in pregnancy
2. I am satisfied with my knowledge about whooping cough vaccination in pregnancy 4 2
3. I am not satisfied about my knowledge about whooping cough vaccination in pregnancy 23 19
4. I feel I lack knowledge about whooping cough vaccination in pregnancy 20 21
Pretest comment ‘I am unsure about the timings’
Post-test comments ‘I do not know if it is safe in pregnancy’
‘I do not know anything about whooping cough vaccination in pregnancy’
‘I have never heard of it’
‘I am unsure about time-frames and risks’
Pretest Post-test
1. I have already personally vaccinated a pregnant woman against whooping cough myself 1
2. I am happy to vaccinate the pregnant woman myself but have not yet had an opportunity to do so 8 9
3. I would not feel confident in vaccinating the pregnant woman myself but would do so after checking details with my
nurse or online as it is a government recommendation
32 27
4. I am not happy about vaccinating a pregnant woman against whooping cough at present 5 5
5. I would not vaccinate a pregnant woman against whooping cough 2
Pretest comments: ‘Is it needed if the mum has had childhood vaccination?’
‘I am unsure about the indications or reasons not to vaccinate’
‘I am not confident as I am not sure it is safe?’
‘It is not a live vaccine so I am happy to vaccinate’
Post-test comments: ‘I would check with an expert and contact the national vaccination programme to gain advice’
‘I would vaccinate if my GP or nurse tells me it is standard practice’
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5. Have you any concerns about harm to the woman? Please delete the responses not applicable leaving the response you
most agree with.
6. Have you any concerns about harm to the baby? Please delete the responses not applicable leaving the response you
most agree with.
7. a) Do you think GPs are best placed to vaccinate pregnant women?
Yes31 32 No3 3 Don’t know4 2
b) Who do you think should be doing this procedure?
Don’t know3. 2 Midwife9. 7 Practice nurse15. 12 GP18. 26 med student1. Obstetrician2. 5 Health
Visitor1. Paediatrician1 anyone appropriately trained3
Comment: ‘I think midwives would be more cost effective than GPs’
8. State what you think is the national uptake rate of whooping cough vaccination in pregnancy at present in%?
590% range. 580% range. 510%5. 1530%14 16 3150% 5 3 5160% 5 5
9. If you were to vaccinate in your next surgery what is the name of the vaccine you would use?
Don’t know30 46 DTP and pertussis1. Varied incorrect5
10. Have you done any routine baby immunisations in the last 12 months? Y7 3 No33 36
11. Would a pregnant woman attending you be given written information about whooping cough vaccination? Y25 34
No2 Don’t know13 8
12. Please write any comments below which would help me in understanding student thoughts, feelings and approaches to
whooping cough vaccination in pregnancy including any further training you may have wanted.
Pretest comments:
‘I think more teaching should be given on issues such as this which change and have a big impact’
‘I have received no formal teaching on this but know it is offered but not sure when’
‘The only contact/info I have had re this has been through personal attendance at a GP surgery when I picked up a leaflet
and read it’
‘I don’t have any knowledge of this’
Post-test comments:
‘I know very little about this and would like to know more’
‘I don’t think medical students can give vaccinations’
Pretest Post-test
1. Yes I have a lot of concern about harm to the woman 2 6
2. Yes I have some concerns about harm to the woman 7
3. I am unsure whether there may be harm or not to the woman 20 23
4. I am fairly sure I have no concerns about harm to the woman 5
5. I have no concerns about harm to the woman 5 1
Pretest comments: ‘There may be a risk of flu like illness and anaphylaxis’
‘There may be a risk of flu and anaphylaxis like any vaccination’
‘It might depend if it is a live vaccine (I have some concerns)’
Post-test comments ‘I do not know what harm the vaccine can cause and whether this would be different in a pregnant woman’
‘I do not know about vaccinations in pregnancy’
Pretest Post-test
1. Yes I have a lot of concern about harm to the baby 4 7
2. Yes I have some concerns about harm to the baby 10 5
3. I am unsure whether there may be harm or not to the baby 22 23
4, I am fairly sure I have no concerns about harm to the baby 10 7
5. I have no concerns about harm to the baby
Pretest comments: ‘I think there is a very small risk to the baby as with any vaccination it is not 100% safe’
‘I would need to read more about it’
Post-test comment: ‘I do not know if it is harmful to the baby or not’
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‘I don’t know much about it’
‘This is an area I have little knowledge of’
‘I would like to have more information on the effects of vaccinations in pregnancy in general, not only whooping cough’
‘I have no knowledge so do not feel I can give the vaccine’
‘I have no idea what this is and want to know the benefit to the baby mainly’
‘I know very little about this’
‘I do not know enough about whooping cough vaccination in pregnancy to make decisions upon giving it or not giving it’
‘I need more education surrounding this’
‘If I knew more about it and there was the right evidence I would be happy to give it’
‘I have never heard of it’
‘I honestly don’t know anything about this topic’
Thank you.
Appendix 2. Tutor sheet regarding aspirin (November 2013)
Appendix 3. Tutor sheet regarding tiotropium (December 2013)
Should patients who have had a heart attack take long-term aspirin?
At present students would be considered to be ‘doing well’ if they identified that the UK guideline is to provide patients with aspirin after
a heart attack (MI) and be able to write this prescription safely, identify that it may cause wheeze or peptic ulceration and understand
that it acts as an antiplatelet.
During a short teaching intervention students will be guided to consider the patient perspective:
Consider BNF facts about aspirin
How useful is it to the patient?
What are the risks of harm to the patient?
Drug use is considered in terms of Beauchamp and Childress’ 4 ethical principles:
In order to consider ethical issues students require more than guidelines, they require an evidence base. Evidence bases can found in
NICE full guidelines and patient decision aids, also provided by NICE (previously by the National Prescribing Centre). There are other
useful sources which students may subsequently research.
So for the scenario above the evidence would be:
Do good for the patient: Aspirin is known to reduce death from MI and cardiovascular events in patients who have had a MI. A 1970s
study suggested that placebo (no aspirin or anticoagulant) patients had a death rate of about 8.5% over an average follow up of 22
months, reduced to 5.8% by quite high dose aspirin.
Do no harm to the patient: The CURE study had a rate of major bleeding in non-STelevation (less severe) MI patients of 2.7% on aspirin.
Students may want to think about definitions of major bleeding; general non-adherence rates for patients on long-term therapy and
reasons for these; changes in patients’ susceptibility to harms over their lifetime.
Patients’ informed decision-making: Given the evidence, how would the students as doctors present the evidence to a patient? Is the
evidence what they would have expected themselves?
Justice to the patient and to society: Students and doctors overestimate the benefits of medications at an individual level but a nearly
3% reduction in second MI and angina after a first MI throughout society (28% of all deaths in the England and Wales in 2012 were due
to CHD and stroke) is very significant.
The students would be signposted to relevant resources by the tutor initially.
How useful is tiotropium for patients with COPD?
At present students would be considered to be ‘doing well’ if they identified that the UK guideline is to provided patients with tiotropium
with COPD and be able to write this prescription safely, identify that it may cause a dry mouth and understand that it acts as an
anticholinergic/antimuscarinic drug.
During a short teaching intervention students will be guided to consider the patient perspective:
BNF facts
How useful is it to the patient?
What are the risks of harm to the patient?
Drug use will be considered in terms of Beauchamp and Childress’ 4 ethical principles:
Facts: indication: maintenance COPD
Cautions: if eGFRB50 ml/min, benign prostatic hypertrophy (BPH), bladder outflow obstruction, susceptible to acute angle eye glaucoma.
Jane Wilcock and Janet Strivens
10
(page number not for citation purpose)
Citation: Med Educ Online 2015, 20: 27097 - http://dx.doi.org/10.3402/meo.v20.27097
Appendix 4. Tutor sheet regarding simvastatin (January 2014)
Side-effects: dry mouth, constipation, tachycardia, cough, paradoxical bronchospasm, palpitations, AF, headache, dizzy, urinary
retention, blurred vision, dyspepsia, taste disturbance.
Interactions: discuss liver metabolised drugs
In order to consider the ethical issues here the students require more than guidelines. They require an evidence base. The evidence
bases can found in NICE full guidelines and patient decision aids, also provided by NICE (previously by NPC). There are of course other
sources that may be useful and it will be up to students subsequently to find best evidence.
So for the scenario above the evidence would be:
A long-term evaluation of once daily inhaled tiotropium in COPD; R. Casaburi et al. European Respiratory Journal Feb1, 2002, vol. 19 no
2 p. 217224.
This is a major reference used in initial decision-making by NICE in including tiotropium in COPD guidance.
British Thoracic Society (BTS) guidelines also refer to NICE guidance.
This was a double-blind placebo randomised trial of inhaler without tiotropium and inhaler with tiotropium
921 patients ages 65 99 years with stable COPD. Is this reasonable?
Exclusions: last 4 weeks patients had had an exacerbation of COPD or a MI in the last 1 year of congestive cardiac failure (CCF) last 3
years or had a heart arrhythmia on medication. Is this reasonable?
Mean screening FEV1 was 39.1% vs. 38.1% of predicted
Measured changes were in FEV1, SOB, health status, medication use and adverse effects
81% tiotropium and 72% of placebo patients completed the study
9.6% tiotropium patients stopped due to adverse effects versus 13.7% of placebo.
2.4% tiotropium patients stopped due to lack of efficacy and 7% in placebo
There was less wheeze, superior health scores, fewer COPD exacerbations, fewer hospitalisations.
There was no difference in cough or chest tightness.
Side-effects: Tiotropium dry mouth 16% and 2.7% in placebo, other side-effects were at similar rates.
Action effects: morning baseline placebo PEFR: 190 increased to 205 at 1 year and evening PEFR 205 L increased to 210 L. Tiotropium
baseline morning PEFR was also 190 L and improved at 1 year to mean 230 L and evening 215 to 240 L.
Bottom line: dry mouth 16% and 30 ml improvement in PEFR.
How does that make us feel about the medication? Is it worth giving? Is it worth pushing the patient if they don’t want another inhaler?
Do good for the patient: improved PEFR and other scores. Mean improvement 30 ml so modest.
Do no harm to the patient: 16% dry mouth
Patients’ informed decision-making: Given the evidence, how would the students as doctors present the evidence to a patient? Is the
evidence what they would have expected themselves?
Justice to the patient and to society: Students and doctors overestimate the benefits of medications at an individual level but a 30 ml
gain in PEFR may be helpful to individuals: it also demonstrates how irreversible COPD is.
The students would be signposted to relevant resources by the tutor initially.
Should patients who have had a MI or angina take simvastatin 40 mg one at night?
At present students would be considered to be ‘doing well’ if they identified that the UK guideline is to provided patients with a statin
after a MI and be able to write this prescription safely, identify that it may cause muscle pain, is liver metabolised and understand that it
acts at the liver to reduce cholesterol.
During a short teaching intervention students will be guided to consider the patient perspective:
BNF facts
How useful is it to the patient?
What are the risks of harm to the patient?
Drug use will be considered in terms of Beauchamp and Childress’ 4 ethical principles:
In order to consider the ethical issues here the students require more than guidelines. They require an evidence base. The evidence
bases can found in NICE full guidelines and patient decision aids, also provided by NICE (previously by NPC). There are of course other
sources that may be useful and it will be up to students subsequently to find best evidence.
So for the scenario above the evidence would be:
Do good for the patient: Reduces second MIs and acts in primary prevention to reduce CHD.
Do no harm to the patient: acts as a competitive inhibitor of HMG CoA reductase, an enzyme involved in cholesterol synthesis
especially in the liver so has a number of liver metabolised drug interactions
Indications: primary hypercholesterolaemia, prevention of cardiovascular events in patients with diabetes mellitus after coronary risk
assessment (CRA), prevention of further atherosclerosis or primary prevention in those with a high CRA
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Caution eGFR B30 ml/min: reduce dose. Correct hypothyroidism, liver disease, caution in high alcohol intake
Monitoring: NICE 2008: liver function tests (LFTs) before starting and within 3 months and at 12 months of starting therapy. ALT above
3 of normal: stop statin. Do not use if increased risk of rhabdomyolysis and patients should report muscle pain.
Acute porphyria is a contraindication as is pregnancy. Patients should use contraception on statins and one month afterwards to
prevent possible teratogenicity. Avoid breast feeding.
SEs: myositis, rhabdomyolysis, pancreatitis is rare, GIT disturbance, hepatitis, jaundice, sleep disturbance, rash and others, very rarely
pulmonary fibrosis so patients should report a cough to their GP. If myopathy is suspected and creatine kinase is 5 the upper limit of
normal or severe symptoms stop therapy.
How do we know it works? How do we measure this?
Patients’ informed decision-making: Given the evidence, how would the students as doctors present the evidence to a patient? Is the
evidence what they would have expected themselves?
Randomised trial of cholesterol lowering in 4,444 patients (3570 years old) with CHD; patients had angina or previous MI and all on
lipid-lowering diet with cholesterol 5.58 mmol/L. Double-blind randomised trial to simvastatin or placebo, patient were followed up 5.4
years and simvastatin produced a mean 25% reduction in cholesterol and 35% reduction in LDL (1.3 mmol/L reduction) and 8%
increase in HDL.
How many patients died and how many had CHD?
12% (256 pts) placebo group died and 8% (182) in the statin group: 4% improvement in CHD life expectancy in the group over 5 years.
189 deaths from CHD in the placebo group (8.5%) and 111 in statin group (5%) and similar non- CHD deaths, about 50 each group
(3.5% improvement in survival)
Placebo risk of surviving over the years was 88% with a 28% chance having another CHD event but this was reduced to a 19% chance
in simvastatin group.
After the trial both groups were offered simvastatin and over 80% of each group continued on simvastatin, initially at 20 mg a day. FU
10.4 years total. 414 pts died on statin and 468 who were originally placebo patients died in 10 years. CHD deaths on statin 238 (11%)
and 300 on placebo (13.5%). There were 85 cancers on statin and 100 in placebo group with a similar but slightly increased cancer
incidence in placebo group.
75% of LDL cholesterol lowering occurs at 20 mg of simvastatin and 6% extra at 40 mg.
The SEARCH Trial showed no increased benefit of 80 mg simvastatin versus 20 mg simvastatin for mortality and morbidity.
Justice to the patient and to society: Students and doctors overestimate the benefits of medications at an individual level but benefits in
society are substantial across groups with CHD.
The students would be signposted to relevant resources by the tutor initially.
www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON199561
Scandinavian simvastatin survival study of 1994 is often called the 4S trial, published in the Lancet
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